

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of macroautophagy (GO:0016242) | 5.77425046 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.31348347 |
| 3 | microglial cell activation (GO:0001774) | 5.15230047 |
| 4 | auditory receptor cell stereocilium organization (GO:0060088) | 5.08813190 |
| 5 | energy homeostasis (GO:0097009) | 5.06174254 |
| 6 | detection of other organism (GO:0098543) | 4.94897810 |
| 7 | post-embryonic morphogenesis (GO:0009886) | 4.88652365 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85190976 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.80938570 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.45223718 |
| 11 | sulfate transmembrane transport (GO:1902358) | 4.42339587 |
| 12 | detection of bacterium (GO:0016045) | 4.29337344 |
| 13 | cellular anion homeostasis (GO:0030002) | 4.24920845 |
| 14 | * macrophage activation (GO:0042116) | 4.10588951 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.09352759 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.00296279 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.00296279 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.00296279 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.00296279 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.00296279 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.00296279 |
| 22 | * detection of biotic stimulus (GO:0009595) | 3.97331084 |
| 23 | neutrophil mediated immunity (GO:0002446) | 3.96483926 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95809417 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.91550569 |
| 26 | trivalent inorganic anion homeostasis (GO:0072506) | 3.84553365 |
| 27 | phosphate ion homeostasis (GO:0055062) | 3.84553365 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84536955 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.82508937 |
| 30 | myeloid cell activation involved in immune response (GO:0002275) | 3.81482897 |
| 31 | neutrophil activation (GO:0042119) | 3.81417439 |
| 32 | negative regulation of mast cell activation (GO:0033004) | 3.78224915 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.74964789 |
| 34 | sulfate transport (GO:0008272) | 3.73713273 |
| 35 | leukocyte aggregation (GO:0070486) | 3.73336136 |
| 36 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.71887012 |
| 37 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.70295335 |
| 38 | response to interleukin-15 (GO:0070672) | 3.58684799 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.57910169 |
| 40 | positive T cell selection (GO:0043368) | 3.54159590 |
| 41 | granulocyte activation (GO:0036230) | 3.51607048 |
| 42 | myeloid leukocyte mediated immunity (GO:0002444) | 3.50475346 |
| 43 | T-helper 1 type immune response (GO:0042088) | 3.45262596 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.43061439 |
| 45 | regulation of activation of Janus kinase activity (GO:0010533) | 3.41899881 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.38385498 |
| 47 | * detection of molecule of bacterial origin (GO:0032490) | 3.33632119 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.32983118 |
| 49 | * positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.32469708 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.30043839 |
| 51 | cellular response to interleukin-15 (GO:0071350) | 3.25702529 |
| 52 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.24505456 |
| 53 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.22758272 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 3.22313750 |
| 55 | defense response to protozoan (GO:0042832) | 3.21799805 |
| 56 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.21209647 |
| 57 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19765904 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.15727197 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.15660188 |
| 60 | regulation of mast cell activation (GO:0033003) | 3.15337868 |
| 61 | inner ear receptor stereocilium organization (GO:0060122) | 3.15165646 |
| 62 | lateral ventricle development (GO:0021670) | 3.14705306 |
| 63 | response to pheromone (GO:0019236) | 3.13555158 |
| 64 | glycoside metabolic process (GO:0016137) | 3.13432171 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13364071 |
| 66 | negative regulation of meiosis (GO:0045835) | 3.13227986 |
| 67 | B cell homeostasis (GO:0001782) | 3.12646526 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 3.10281600 |
| 69 | B cell mediated immunity (GO:0019724) | 3.10039955 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09554546 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08838246 |
| 72 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.08609245 |
| 73 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.08146416 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.07970500 |
| 75 | regulation of B cell differentiation (GO:0045577) | 3.05787524 |
| 76 | germinal center formation (GO:0002467) | 3.05655176 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05279680 |
| 78 | interferon-gamma production (GO:0032609) | 3.02591393 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 3.01604565 |
| 80 | negative thymic T cell selection (GO:0045060) | 3.00583623 |
| 81 | positive regulation of macrophage cytokine production (GO:0060907) | 2.98724328 |
| 82 | negative T cell selection (GO:0043383) | 2.97489910 |
| 83 | T cell migration (GO:0072678) | 2.96678535 |
| 84 | dendritic cell migration (GO:0036336) | 2.96550053 |
| 85 | regulation of macrophage cytokine production (GO:0010935) | 2.94628311 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94502809 |
| 87 | negative regulation of interleukin-17 production (GO:0032700) | 2.94247521 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 2.94153384 |
| 89 | positive regulation of mast cell degranulation (GO:0043306) | 2.93794324 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.93794324 |
| 91 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.90863068 |
| 92 | positive regulation of interferon-beta production (GO:0032728) | 2.88984003 |
| 93 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88911610 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88911610 |
| 95 | * myeloid leukocyte activation (GO:0002274) | 2.87990510 |
| 96 | regulation of T cell tolerance induction (GO:0002664) | 2.87631348 |
| 97 | positive regulation of interferon-alpha production (GO:0032727) | 2.87185170 |
| 98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86393641 |
| 99 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86187834 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.85095424 |
| 101 | * regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.84962187 |
| 102 | macrophage activation involved in immune response (GO:0002281) | 2.83223327 |
| 103 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.82650419 |
| 104 | positive regulation of antigen processing and presentation (GO:0002579) | 2.80578633 |
| 105 | I-kappaB phosphorylation (GO:0007252) | 2.79841109 |
| 106 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.79584900 |
| 107 | negative regulation of interleukin-12 production (GO:0032695) | 2.79064745 |
| 108 | response to host immune response (GO:0052572) | 2.77232435 |
| 109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77232435 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72628131 |
| 111 | thymic T cell selection (GO:0045061) | 2.72224656 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72182642 |
| 113 | B cell proliferation (GO:0042100) | 2.72000298 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.71912740 |
| 115 | lymphocyte homeostasis (GO:0002260) | 2.71338661 |
| 116 | response to type I interferon (GO:0034340) | 2.69141410 |
| 117 | negative regulation of B cell proliferation (GO:0030889) | 2.67532972 |
| 118 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.66601366 |
| 119 | prostate gland growth (GO:0060736) | 2.65250705 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.63493693 |
| 121 | cellular response to type I interferon (GO:0071357) | 2.63493693 |
| 122 | negative regulation of cell killing (GO:0031342) | 2.62718591 |
| 123 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.62718591 |
| 124 | positive regulation of heat generation (GO:0031652) | 2.62676396 |
| 125 | bicarbonate transport (GO:0015701) | 2.61819545 |
| 126 | negative regulation of granulocyte differentiation (GO:0030853) | 2.61242783 |
| 127 | T cell selection (GO:0045058) | 2.59171691 |
| 128 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.58931290 |
| 129 | negative regulation of response to nutrient levels (GO:0032108) | 2.58931290 |
| 130 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.57179865 |
| 131 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.56943674 |
| 132 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56797695 |
| 133 | cellular extravasation (GO:0045123) | 2.55566383 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.55277634 |
| 135 | response to peptidoglycan (GO:0032494) | 2.54992037 |
| 136 | modulation by virus of host process (GO:0019054) | 2.54984336 |
| 137 | * detection of external biotic stimulus (GO:0098581) | 2.54596271 |
| 138 | positive regulation of neurological system process (GO:0031646) | 2.54211208 |
| 139 | cell proliferation involved in metanephros development (GO:0072203) | 2.53392800 |
| 140 | monocyte chemotaxis (GO:0002548) | 2.51830649 |
| 141 | positive regulation of protein homooligomerization (GO:0032464) | 2.51167073 |
| 142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.50918389 |
| 143 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.50918389 |
| 144 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.50014566 |
| 145 | neuron remodeling (GO:0016322) | 2.48412572 |
| 146 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.48310456 |
| 147 | histone H3-K9 modification (GO:0061647) | 2.47781137 |
| 148 | T cell homeostasis (GO:0043029) | 2.47408476 |
| 149 | modulation by symbiont of host cellular process (GO:0044068) | 2.47347575 |
| 150 | respiratory burst (GO:0045730) | 2.46822103 |
| 151 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.46376475 |
| 152 | response to host (GO:0075136) | 2.45297542 |
| 153 | response to host defenses (GO:0052200) | 2.45297542 |
| 154 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.45297542 |
| 155 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.44928187 |
| 156 | polyketide metabolic process (GO:0030638) | 16.3564667 |
| 157 | doxorubicin metabolic process (GO:0044598) | 16.3564667 |
| 158 | daunorubicin metabolic process (GO:0044597) | 16.3564667 |
| 159 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.5486131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.68709953 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.48471124 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.79434045 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.69860513 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.47435133 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.39510473 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16563783 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.83330135 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.75965734 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56758334 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.51485761 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33723296 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.30274429 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28811307 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.25873790 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.23436498 |
| 17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20184010 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16957446 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15321237 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11466576 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.08640039 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06679590 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.98203744 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96715978 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94908442 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93038575 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88491763 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82641329 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82086400 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77905649 |
| 31 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74357927 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69901643 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.68993529 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67764916 |
| 35 | RXR_22108803_ChIP-Seq_LS180_Human | 1.65285209 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64839316 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53187902 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51611913 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50311480 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49971968 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47479045 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46428019 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45318486 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44982169 |
| 45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42731550 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39756859 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.37902442 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.37890655 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37435030 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35377276 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34878938 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32773876 |
| 53 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27699571 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26010030 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25726563 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.25024720 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24715466 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22607777 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22015266 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21797811 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21053268 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18214283 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17934681 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17803056 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.16473639 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15642165 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15045483 |
| 68 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.14975076 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14713776 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13007128 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12846668 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12544090 |
| 73 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12406652 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12226934 |
| 75 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11936988 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10498920 |
| 77 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10226360 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09757609 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09657837 |
| 80 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09602257 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09263449 |
| 82 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08954893 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08954893 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08395601 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07905205 |
| 86 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07462498 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07036510 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06709835 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05934300 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03604446 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02874568 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02533084 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02397794 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01783825 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01104936 |
| 96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00715559 |
| 97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00693880 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99898316 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99366650 |
| 100 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98456282 |
| 101 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98226892 |
| 102 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98186015 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98051256 |
| 104 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.98044237 |
| 105 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.97302786 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96758629 |
| 107 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96708718 |
| 108 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96463286 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95000561 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94441296 |
| 111 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94379588 |
| 112 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94008551 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 0.93993869 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93863459 |
| 115 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.93766506 |
| 116 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.92690003 |
| 117 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92514315 |
| 118 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92356727 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92120017 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91239801 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89641028 |
| 122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89421233 |
| 123 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88973354 |
| 124 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.88762226 |
| 125 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88684804 |
| 126 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87063834 |
| 127 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86716206 |
| 128 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86626349 |
| 129 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86387619 |
| 130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86323613 |
| 131 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86111998 |
| 132 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85146938 |
| 133 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84802889 |
| 134 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84744163 |
| 135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84282350 |
| 136 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.84214343 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84078406 |
| 138 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83427103 |
| 139 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.83284797 |
| 140 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83017296 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82759882 |
| 142 | VDR_22108803_ChIP-Seq_LS180_Human | 0.82659214 |
| 143 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.82397505 |
| 144 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81863849 |
| 145 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81469914 |
| 146 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77659060 |
| 147 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76958396 |
| 148 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73458883 |
| 149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.64869466 |
| 150 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64799764 |
| 151 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62733355 |
| 152 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62118123 |
| 153 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.61984098 |
| 154 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61599972 |
| 155 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.60774539 |
| 156 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.60362734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005377_hearing/vestibular/ear_phenot | 5.47202227 |
| 2 | MP0003878_abnormal_ear_physiology | 5.47202227 |
| 3 | MP0008004_abnormal_stomach_pH | 5.09944836 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.46638982 |
| 5 | MP0001790_abnormal_immune_system | 3.20243929 |
| 6 | MP0005387_immune_system_phenotype | 3.20243929 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 2.91700457 |
| 8 | MP0005671_abnormal_response_to | 2.83426155 |
| 9 | * MP0001800_abnormal_humoral_immune | 2.68263742 |
| 10 | MP0002277_abnormal_respiratory_mucosa | 2.57233255 |
| 11 | MP0003879_abnormal_hair_cell | 2.52499970 |
| 12 | MP0008260_abnormal_autophagy | 2.45259962 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.42442014 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.41480176 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.36341239 |
| 16 | MP0009785_altered_susceptibility_to | 2.31373011 |
| 17 | MP0009697_abnormal_copulation | 2.30931723 |
| 18 | MP0000678_abnormal_parathyroid_gland | 2.30516829 |
| 19 | MP0000685_abnormal_immune_system | 2.27500183 |
| 20 | MP0002419_abnormal_innate_immunity | 2.17867360 |
| 21 | * MP0002723_abnormal_immune_serum | 2.15810970 |
| 22 | MP0003303_peritoneal_inflammation | 2.03720553 |
| 23 | MP0003436_decreased_susceptibility_to | 2.02779842 |
| 24 | MP0001986_abnormal_taste_sensitivity | 2.02254448 |
| 25 | MP0001819_abnormal_immune_cell | 2.01873805 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.01656755 |
| 27 | MP0005025_abnormal_response_to | 1.97511171 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.92141497 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.88847701 |
| 30 | MP0005451_abnormal_body_composition | 1.86649591 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.82360406 |
| 32 | MP0004742_abnormal_vestibular_system | 1.75728351 |
| 33 | MP0004883_abnormal_blood_vessel | 1.71723721 |
| 34 | MP0009278_abnormal_bone_marrow | 1.71528589 |
| 35 | MP0005310_abnormal_salivary_gland | 1.65149477 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.55635998 |
| 37 | MP0004510_myositis | 1.54580183 |
| 38 | MP0000716_abnormal_immune_system | 1.53943539 |
| 39 | MP0004381_abnormal_hair_follicle | 1.49180816 |
| 40 | MP0002398_abnormal_bone_marrow | 1.48990481 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.48085125 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.48085125 |
| 43 | MP0009764_decreased_sensitivity_to | 1.46263872 |
| 44 | MP0006082_CNS_inflammation | 1.43214567 |
| 45 | MP0003045_fibrosis | 1.42399640 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.39361374 |
| 47 | MP0005164_abnormal_response_to | 1.39104972 |
| 48 | MP0003690_abnormal_glial_cell | 1.38837017 |
| 49 | MP0002132_abnormal_respiratory_system | 1.38585720 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.35907220 |
| 51 | MP0000566_synostosis | 1.34585883 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.32733741 |
| 53 | MP0003724_increased_susceptibility_to | 1.32309370 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.27624977 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.26106073 |
| 56 | MP0003941_abnormal_skin_development | 1.25013968 |
| 57 | MP0000604_amyloidosis | 1.24307445 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.23051550 |
| 59 | MP0002405_respiratory_system_inflammati | 1.22233888 |
| 60 | MP0002006_tumorigenesis | 1.19622959 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.18464204 |
| 62 | MP0002429_abnormal_blood_cell | 1.18052368 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.16226356 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.15184895 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.14839922 |
| 66 | MP0000343_altered_response_to | 1.13840481 |
| 67 | MP0005423_abnormal_somatic_nervous | 1.13668763 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.13068406 |
| 69 | MP0001851_eye_inflammation | 1.12095875 |
| 70 | MP0001853_heart_inflammation | 1.11191166 |
| 71 | MP0002722_abnormal_immune_system | 1.08044618 |
| 72 | MP0003646_muscle_fatigue | 1.07464479 |
| 73 | MP0003866_abnormal_defecation | 1.01920538 |
| 74 | MP0004947_skin_inflammation | 0.98033527 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.97360196 |
| 76 | MP0002735_abnormal_chemical_nociception | 0.97234321 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.96134855 |
| 78 | MP0005257_abnormal_intraocular_pressure | 0.95166647 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.94102360 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90073909 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.89891067 |
| 82 | MP0009763_increased_sensitivity_to | 0.88537209 |
| 83 | MP0001873_stomach_inflammation | 0.87995865 |
| 84 | MP0005166_decreased_susceptibility_to | 0.87836239 |
| 85 | MP0008469_abnormal_protein_level | 0.87719807 |
| 86 | MP0000681_abnormal_thyroid_gland | 0.83554178 |
| 87 | MP0005171_absent_coat_pigmentation | 0.83220696 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.82994939 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.82726895 |
| 90 | MP0003787_abnormal_imprinting | 0.80238939 |
| 91 | MP0000858_altered_metastatic_potential | 0.79301383 |
| 92 | MP0000470_abnormal_stomach_morphology | 0.75973773 |
| 93 | MP0000249_abnormal_blood_vessel | 0.75612250 |
| 94 | MP0004130_abnormal_muscle_cell | 0.74477096 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.73845633 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.73360174 |
| 97 | MP0002098_abnormal_vibrissa_morphology | 0.73026719 |
| 98 | MP0001663_abnormal_digestive_system | 0.72822188 |
| 99 | MP0008874_decreased_physiological_sensi | 0.72188781 |
| 100 | MP0003448_altered_tumor_morphology | 0.72180657 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.72071972 |
| 102 | MP0006276_abnormal_autonomic_nervous | 0.71890060 |
| 103 | MP0004484_altered_response_of | 0.71778528 |
| 104 | MP0002928_abnormal_bile_duct | 0.71559417 |
| 105 | MP0000371_diluted_coat_color | 0.71203243 |
| 106 | MP0003795_abnormal_bone_structure | 0.70168898 |
| 107 | MP0002933_joint_inflammation | 0.70070969 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.69467389 |
| 109 | MP0003091_abnormal_cell_migration | 0.69045889 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.68497239 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.68062642 |
| 112 | MP0003868_abnormal_feces_composition | 0.67880443 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.67264485 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.66866151 |
| 115 | MP0005646_abnormal_pituitary_gland | 0.66085070 |
| 116 | MP0006054_spinal_hemorrhage | 0.65962044 |
| 117 | MP0003075_altered_response_to | 0.64765959 |
| 118 | MP0002163_abnormal_gland_morphology | 0.63204741 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.62813781 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.62599752 |
| 121 | MP0003329_amyloid_beta_deposits | 0.62200781 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.62158057 |
| 123 | MP0005390_skeleton_phenotype | 0.62077241 |
| 124 | MP0001501_abnormal_sleep_pattern | 0.61690388 |
| 125 | MP0001486_abnormal_startle_reflex | 0.59845336 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.59752672 |
| 127 | MP0005647_abnormal_sex_gland | 0.59686331 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.59227954 |
| 129 | MP0002009_preneoplasia | 0.58930072 |
| 130 | MP0002138_abnormal_hepatobiliary_system | 0.57401101 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.55876379 |
| 132 | MP0009840_abnormal_foam_cell | 0.55154338 |
| 133 | MP0003828_pulmonary_edema | 0.54840840 |
| 134 | MP0005388_respiratory_system_phenotype | 0.53869445 |
| 135 | MP0002133_abnormal_respiratory_system | 0.53869445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 7.89041132 |
| 2 | Alopecia of scalp (HP:0002293) | 6.92839905 |
| 3 | Unilateral renal agenesis (HP:0000122) | 6.68949497 |
| 4 | Bilateral sensorineural hearing impairment (HP:0008619) | 5.92812443 |
| 5 | Chronic otitis media (HP:0000389) | 5.91358526 |
| 6 | Follicular hyperkeratosis (HP:0007502) | 5.66428602 |
| 7 | Cheilitis (HP:0100825) | 5.61334037 |
| 8 | Abnormality of dental color (HP:0011073) | 5.00207621 |
| 9 | Absent eyebrow (HP:0002223) | 4.58314506 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.33013236 |
| 11 | Absent eyelashes (HP:0000561) | 4.21535491 |
| 12 | Recurrent corneal erosions (HP:0000495) | 4.09492434 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 4.03463407 |
| 14 | T lymphocytopenia (HP:0005403) | 3.86730588 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.85398249 |
| 16 | Chronic sinusitis (HP:0011109) | 3.79144906 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.72032420 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.71445181 |
| 19 | Encephalitis (HP:0002383) | 3.56700598 |
| 20 | Hyperphosphatemia (HP:0002905) | 3.56333967 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.56150249 |
| 22 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.54165068 |
| 23 | Absent/shortened dynein arms (HP:0200106) | 3.54165068 |
| 24 | Arterial thrombosis (HP:0004420) | 3.32297148 |
| 25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.29458003 |
| 26 | Hemoptysis (HP:0002105) | 3.28817084 |
| 27 | Peritonitis (HP:0002586) | 3.28419388 |
| 28 | Tetany (HP:0001281) | 3.27622613 |
| 29 | Abolished electroretinogram (ERG) (HP:0000550) | 3.24428376 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 3.23000520 |
| 31 | Chest pain (HP:0100749) | 3.22793885 |
| 32 | Ectropion (HP:0000656) | 3.20753312 |
| 33 | Mitral stenosis (HP:0001718) | 3.14911503 |
| 34 | Lymphopenia (HP:0001888) | 3.14489333 |
| 35 | Prostate neoplasm (HP:0100787) | 3.11982689 |
| 36 | Erythroderma (HP:0001019) | 3.11696941 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.10318443 |
| 38 | Agammaglobulinemia (HP:0004432) | 2.99854003 |
| 39 | Leukocytosis (HP:0001974) | 2.99149526 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98215503 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87935164 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87935164 |
| 43 | Blepharitis (HP:0000498) | 2.87555013 |
| 44 | Urticaria (HP:0001025) | 2.83586891 |
| 45 | Vasculitis (HP:0002633) | 2.82992111 |
| 46 | Chronic diarrhea (HP:0002028) | 2.81005118 |
| 47 | Pulmonary embolism (HP:0002204) | 2.79351860 |
| 48 | Abnormality of T cells (HP:0002843) | 2.77216026 |
| 49 | Epistaxis (HP:0000421) | 2.75982329 |
| 50 | Anorexia (HP:0002039) | 2.72497806 |
| 51 | Gastrointestinal stroma tumor (HP:0100723) | 2.71323142 |
| 52 | Renal dysplasia (HP:0000110) | 2.71270290 |
| 53 | Recurrent fungal infections (HP:0002841) | 2.70793605 |
| 54 | Amyloidosis (HP:0011034) | 2.70434651 |
| 55 | Keratitis (HP:0000491) | 2.68582062 |
| 56 | Increased IgE level (HP:0003212) | 2.68079551 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66524403 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66524403 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66524403 |
| 60 | Stomatitis (HP:0010280) | 2.64665186 |
| 61 | Gangrene (HP:0100758) | 2.63448379 |
| 62 | Recurrent pneumonia (HP:0006532) | 2.56218767 |
| 63 | Episodic fever (HP:0001954) | 2.54249251 |
| 64 | Recurrent sinusitis (HP:0011108) | 2.52243137 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.49541610 |
| 66 | Optic neuritis (HP:0100653) | 2.49541610 |
| 67 | Abnormality of the peritoneum (HP:0002585) | 2.47097915 |
| 68 | Osteomyelitis (HP:0002754) | 2.46935677 |
| 69 | Abnormality of the prostate (HP:0008775) | 2.45921207 |
| 70 | Neoplasm of the lung (HP:0100526) | 2.45426707 |
| 71 | Myositis (HP:0100614) | 2.45397575 |
| 72 | Meningitis (HP:0001287) | 2.44947466 |
| 73 | Recurrent skin infections (HP:0001581) | 2.44553459 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44021332 |
| 75 | Small epiphyses (HP:0010585) | 2.41555494 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.40589757 |
| 77 | Granulocytopenia (HP:0001913) | 2.38207327 |
| 78 | Recurrent viral infections (HP:0004429) | 2.35872633 |
| 79 | Pustule (HP:0200039) | 2.35571904 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.35084622 |
| 81 | Obstructive lung disease (HP:0006536) | 2.34711119 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34711119 |
| 83 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33943182 |
| 84 | Palmoplantar hyperkeratosis (HP:0000972) | 2.30803685 |
| 85 | Inflammation of the large intestine (HP:0002037) | 2.29123227 |
| 86 | Abnormality of the endocardium (HP:0004306) | 2.28802850 |
| 87 | Plagiocephaly (HP:0001357) | 2.28794246 |
| 88 | Palmar hyperkeratosis (HP:0010765) | 2.28623380 |
| 89 | Orchitis (HP:0100796) | 2.26407910 |
| 90 | Eosinophilia (HP:0001880) | 2.24309739 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 2.22349401 |
| 92 | Erythema (HP:0010783) | 2.20404710 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 2.20345489 |
| 94 | Slow saccadic eye movements (HP:0000514) | 2.20272320 |
| 95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.19432321 |
| 96 | Sepsis (HP:0100806) | 2.19156528 |
| 97 | Glomerulopathy (HP:0100820) | 2.16580170 |
| 98 | Gingivitis (HP:0000230) | 2.15883264 |
| 99 | Hypochromic anemia (HP:0001931) | 2.15785482 |
| 100 | Viral hepatitis (HP:0006562) | 2.14151128 |
| 101 | Systemic lupus erythematosus (HP:0002725) | 2.11587308 |
| 102 | Absent hair (HP:0002298) | 2.11166696 |
| 103 | Neoplasm of the respiratory system (HP:0100606) | 2.09077069 |
| 104 | Colitis (HP:0002583) | 2.08769047 |
| 105 | Pulmonary infiltrates (HP:0002113) | 2.08690668 |
| 106 | Subacute progressive viral hepatitis (HP:0006572) | 2.08097838 |
| 107 | Recurrent bronchitis (HP:0002837) | 2.07490703 |
| 108 | Periodontitis (HP:0000704) | 2.07310990 |
| 109 | Vertebral arch anomaly (HP:0008438) | 2.07066549 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 2.04301169 |
| 111 | Increased IgM level (HP:0003496) | 2.03956668 |
| 112 | Autoimmune hemolytic anemia (HP:0001890) | 2.02901359 |
| 113 | Prolonged bleeding time (HP:0003010) | 2.02797058 |
| 114 | Abnormality of the renal collecting system (HP:0004742) | 2.02723270 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 2.01529998 |
| 116 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.00908170 |
| 117 | Acute hepatic failure (HP:0006554) | 2.00152255 |
| 118 | Vertigo (HP:0002321) | 2.00078469 |
| 119 | Amaurosis fugax (HP:0100576) | 1.99977269 |
| 120 | Thrombophlebitis (HP:0004418) | 1.99319823 |
| 121 | Chronic hepatic failure (HP:0100626) | 1.99232078 |
| 122 | Polyneuropathy (HP:0001271) | 1.99089809 |
| 123 | Basal ganglia calcification (HP:0002135) | 1.98850372 |
| 124 | Cellulitis (HP:0100658) | 1.97714592 |
| 125 | Arthropathy (HP:0003040) | 1.97249335 |
| 126 | Microcytic anemia (HP:0001935) | 1.96048553 |
| 127 | Duplicated collecting system (HP:0000081) | 1.95923940 |
| 128 | Hypergammaglobulinemia (HP:0010702) | 1.95482785 |
| 129 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94922216 |
| 130 | Skin ulcer (HP:0200042) | 1.93577148 |
| 131 | Loss of speech (HP:0002371) | 1.93230724 |
| 132 | Abnormality of eosinophils (HP:0001879) | 1.91805693 |
| 133 | Ectopic kidney (HP:0000086) | 1.91715136 |
| 134 | Petechiae (HP:0000967) | 1.90905412 |
| 135 | Disinhibition (HP:0000734) | 1.90277988 |
| 136 | Panhypogammaglobulinemia (HP:0003139) | 1.89342924 |
| 137 | Acne (HP:0001061) | 1.88266922 |
| 138 | Fatigue (HP:0012378) | 1.85547193 |
| 139 | Hematochezia (HP:0002573) | 1.84647776 |
| 140 | Hyperactive renin-angiotensin system (HP:0000841) | 1.84263803 |
| 141 | Abnormality of macrophages (HP:0004311) | 1.83089020 |
| 142 | Abnormal ciliary motility (HP:0012262) | 1.82187659 |
| 143 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.81641759 |
| 144 | Myocardial infarction (HP:0001658) | 1.81403274 |
| 145 | Gingival bleeding (HP:0000225) | 1.79100327 |
| 146 | Emphysema (HP:0002097) | 1.78626824 |
| 147 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.77463675 |
| 148 | Metabolic alkalosis (HP:0200114) | 1.77342076 |
| 149 | Bone pain (HP:0002653) | 1.74295547 |
| 150 | Abnormality of T cell number (HP:0011839) | 1.74018142 |
| 151 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.72725173 |
| 152 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.72725173 |
| 153 | IgA deficiency (HP:0002720) | 1.72637948 |
| 154 | Abnormal biliary tract physiology (HP:0012439) | 1.72569029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 8.04171571 |
| 2 | SIK2 | 5.46215544 |
| 3 | SIK1 | 4.67716787 |
| 4 | MARK3 | 3.33059800 |
| 5 | MAP4K1 | 3.19720221 |
| 6 | TXK | 3.04333170 |
| 7 | MAP2K3 | 2.82132651 |
| 8 | MAP3K14 | 2.80680176 |
| 9 | MAP3K13 | 2.02685620 |
| 10 | TYK2 | 1.99838169 |
| 11 | IRAK4 | 1.94431423 |
| 12 | BLK | 1.85682322 |
| 13 | IRAK3 | 1.71005556 |
| 14 | JAK3 | 1.69379869 |
| 15 | IKBKE | 1.67998227 |
| 16 | EPHA2 | 1.64899261 |
| 17 | RIPK4 | 1.55018192 |
| 18 | MAP3K3 | 1.48224460 |
| 19 | JAK1 | 1.46612862 |
| 20 | MAP3K2 | 1.44854010 |
| 21 | LATS1 | 1.35244097 |
| 22 | MATK | 1.35025511 |
| 23 | MAP3K1 | 1.33857152 |
| 24 | KSR2 | 1.33767065 |
| 25 | PAK4 | 1.32632410 |
| 26 | PRPF4B | 1.32190397 |
| 27 | PIK3CG | 1.25243000 |
| 28 | TBK1 | 1.21158077 |
| 29 | ADRBK2 | 1.20589053 |
| 30 | ZAP70 | 1.19976600 |
| 31 | SYK | 1.19675155 |
| 32 | TAOK1 | 1.19443579 |
| 33 | IKBKB | 1.18805904 |
| 34 | KIT | 1.17673010 |
| 35 | TEC | 1.13017247 |
| 36 | MAP3K11 | 1.11735587 |
| 37 | STK10 | 1.09590071 |
| 38 | CSF1R | 1.06086093 |
| 39 | MAP3K6 | 1.05363683 |
| 40 | ITK | 1.04792163 |
| 41 | MAP3K12 | 1.04724445 |
| 42 | HCK | 1.04504645 |
| 43 | CSK | 1.02981560 |
| 44 | CDK8 | 1.01633164 |
| 45 | BTK | 1.01053307 |
| 46 | TGFBR2 | 1.00553819 |
| 47 | MARK2 | 0.98044450 |
| 48 | LYN | 0.96939890 |
| 49 | LRRK2 | 0.88266977 |
| 50 | TNK2 | 0.87763381 |
| 51 | ZAK | 0.86124880 |
| 52 | PDK1 | 0.81952806 |
| 53 | SGK2 | 0.81665623 |
| 54 | LCK | 0.81093042 |
| 55 | CAMKK2 | 0.78296703 |
| 56 | FGFR3 | 0.76079597 |
| 57 | MAP3K5 | 0.76068105 |
| 58 | WNK1 | 0.75290840 |
| 59 | PTK2B | 0.72009851 |
| 60 | SGK3 | 0.69366754 |
| 61 | CLK1 | 0.69349323 |
| 62 | GRK7 | 0.69129099 |
| 63 | RAF1 | 0.69021624 |
| 64 | PRKCQ | 0.67513228 |
| 65 | PDPK1 | 0.67372629 |
| 66 | CHUK | 0.66771152 |
| 67 | FGFR4 | 0.65034559 |
| 68 | STK38L | 0.64113306 |
| 69 | RPS6KA4 | 0.63297349 |
| 70 | FES | 0.63217261 |
| 71 | MAP2K4 | 0.62780452 |
| 72 | MST4 | 0.62744573 |
| 73 | YES1 | 0.62301695 |
| 74 | KSR1 | 0.61616357 |
| 75 | TNIK | 0.60484024 |
| 76 | GRK6 | 0.59926242 |
| 77 | NLK | 0.57190918 |
| 78 | CSNK1A1L | 0.56482744 |
| 79 | IRAK2 | 0.54318651 |
| 80 | PIM1 | 0.51518645 |
| 81 | DYRK1B | 0.51489538 |
| 82 | CDC42BPA | 0.51354759 |
| 83 | ACVR1B | 0.51164136 |
| 84 | STK38 | 0.51144747 |
| 85 | PTK6 | 0.50850068 |
| 86 | BMPR2 | 0.50674701 |
| 87 | STK11 | 0.48815150 |
| 88 | STK4 | 0.48721629 |
| 89 | TAOK2 | 0.47855389 |
| 90 | MAP2K6 | 0.47106052 |
| 91 | EIF2AK2 | 0.46837991 |
| 92 | RET | 0.46459303 |
| 93 | CSNK1D | 0.45716738 |
| 94 | NEK9 | 0.45632576 |
| 95 | TAOK3 | 0.44694684 |
| 96 | HIPK2 | 0.43699624 |
| 97 | MAPK12 | 0.43409014 |
| 98 | CDK19 | 0.43084365 |
| 99 | FGR | 0.42427764 |
| 100 | BMPR1B | 0.41403904 |
| 101 | PRKD2 | 0.41235704 |
| 102 | GRK1 | 0.39728979 |
| 103 | CAMK4 | 0.39542839 |
| 104 | CAMK1 | 0.39270514 |
| 105 | NUAK1 | 0.39142816 |
| 106 | IRAK1 | 0.38685877 |
| 107 | EPHB1 | 0.38081576 |
| 108 | EPHA3 | 0.38057263 |
| 109 | CAMKK1 | 0.37634185 |
| 110 | DYRK3 | 0.37466773 |
| 111 | PKN1 | 0.37375327 |
| 112 | INSRR | 0.37227607 |
| 113 | PRKAA2 | 0.37016303 |
| 114 | ERN1 | 0.36757203 |
| 115 | JAK2 | 0.36196656 |
| 116 | CDK6 | 0.35778165 |
| 117 | MAPK11 | 0.35236974 |
| 118 | FRK | 0.35112020 |
| 119 | MAPKAPK2 | 0.34002031 |
| 120 | MOS | 0.33867832 |
| 121 | INSR | 0.33269881 |
| 122 | STK3 | 0.32356648 |
| 123 | MAP3K7 | 0.32168451 |
| 124 | GRK5 | 0.31754870 |
| 125 | EGFR | 0.30228894 |
| 126 | PRKCH | 0.29715559 |
| 127 | FYN | 0.28922953 |
| 128 | ALK | 0.28687946 |
| 129 | MAPK7 | 0.28368576 |
| 130 | CDK12 | 0.26085773 |
| 131 | PRKCD | 0.25663358 |
| 132 | SGK1 | 0.25478095 |
| 133 | RPS6KA6 | 0.24584900 |
| 134 | BRD4 | 0.24402913 |
| 135 | ABL1 | 0.23828216 |
| 136 | MAPK13 | 0.23637775 |
| 137 | CAMK1D | 0.21904990 |
| 138 | RPS6KC1 | 0.21362034 |
| 139 | RPS6KL1 | 0.21362034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.69846023 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.99034443 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.62741965 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48764942 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.35231189 |
| 6 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.35028123 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.25440780 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.22185012 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20671352 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11932385 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96871239 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.90651891 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87765665 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86825478 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.81453251 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.76822541 |
| 17 | Mineral absorption_Homo sapiens_hsa04978 | 1.64963766 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59205131 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55034002 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54064382 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49380294 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46564881 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.46132366 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46114602 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.43443015 |
| 26 | * Tuberculosis_Homo sapiens_hsa05152 | 1.41689484 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.38809316 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38512230 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.34874350 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34290169 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30261856 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28195057 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27852894 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23586944 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23558097 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22264439 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21933500 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.17152598 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16917118 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10378033 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09745473 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05840751 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00195238 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.98516410 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.97854262 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96698834 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.95991301 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.95726317 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94827675 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92287093 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89927472 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.89609896 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85252594 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84320742 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83942848 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.83326779 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83279660 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83154038 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83085700 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83061760 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82537615 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79777126 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79105579 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78795742 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.77592270 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76623579 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74232505 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.69507495 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68352253 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68333934 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67303716 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66615003 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.65974818 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65654238 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65377046 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65274086 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63520205 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.63021533 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62477300 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61975203 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60683170 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60546831 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.60101807 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59718262 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58722816 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.57395093 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57201109 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57063636 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.56454324 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56203338 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56194496 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55505390 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55357408 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54595870 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54543399 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54489451 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54150572 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52446328 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50313782 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50218721 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.49541115 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.47291220 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47177978 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46986683 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45933459 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.42644368 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41788479 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.40935796 |
| 109 | Taste transduction_Homo sapiens_hsa04742 | 0.40708364 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.38769434 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38507146 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37670334 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37596688 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37544723 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37046385 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36941060 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36518031 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.36165202 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35354676 |
| 120 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.32119431 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31791564 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31723702 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.31675681 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31186097 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29617427 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29171794 |

